Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens

The standard of care for patients with acute promyelocytic leukaemia (APL) relapsing after front‐line treatment with arsenic trioxide (ATO)‐based regimens remains to be defined. A total of 67 patients who relapsed after receiving ATO‐based up‐front therapy and were also salvaged using an ATO‐based r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Fouzia, N. A., Sharma, Vibhor, Ganesan, Saravanan, Palani, Hamenth K., Balasundaram, Nithya, David, Sachin, Kulkarni, Uday P., Korula, Anu, Devasia, Anup J., Nair, Sukesh C., Janet, Nancy Beryl, Abraham, Aby, Mani, Thenmozhi, Lakshmanan, Jeyaseelan, Balasubramanian, Poonkuzhali, George, Biju, Mathews, Vikram
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Haematological Malignancy ‐ Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7894296/
https://ncbi.nlm.nih.gov/pubmed/33216980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.17221
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados